• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项比较玻璃体内注射曲安奈德与局灶/格栅光凝治疗糖尿病性黄斑水肿的随机试验:基线特征

A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features.

作者信息

Ip Michael S, Bressler Susan B, Antoszyk Andrew N, Flaxel Christina J, Kim Judy E, Friedman Scott M, Qin Haijing

机构信息

University of Wisconsin Fundus Photograph Reading Center, Madison, WI, USA.

出版信息

Retina. 2008 Jul-Aug;28(7):919-30. doi: 10.1097/IAE.0b013e31818144a7.

DOI:10.1097/IAE.0b013e31818144a7
PMID:18698292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2796075/
Abstract

PURPOSE

To compare baseline demographic, systemic, and ocular characteristics within age and racial subgroups among participants in this Diabetic Retinopathy Clinical Research Network clinical trial and to compare this cohort with other cohorts enrolled in phase 3 clinical trials for diabetic retinopathy.

METHODS

Thirty-six month, randomized, controlled, multicenter clinical trial of 693 participants with diabetic macular edema enrolled at 88 clinical sites in the United States. Participants were categorized into self-reported race/ethnicity subgroups and into one of three age groups: 18 to <60, 60 to <70, and 70 and older.

RESULTS

Mean age of participants was 63 years, 72% were white, and median visual acuity letter score was 62 (approximately 20/63). No substantial difference was identified between racial subgroups for any baseline variable. Older participants were more likely to have Type 2 diabetes mellitus and longer duration disease. The most frequent levels of diabetic retinopathy among 840 study eyes were moderate (level 43) to moderately severe (level 47) nonproliferative disease.

CONCLUSION

While the racial composition of this cohort does not differ from other cohorts in large phase 3 trials that have evaluated participants with diabetic retinopathy, the inclusion of many subjects over age 70 and a better level of glycemic control are distinguishing features.

摘要

目的

比较糖尿病视网膜病变临床研究网络这项临床试验参与者中不同年龄和种族亚组的基线人口统计学、全身和眼部特征,并将该队列与其他参与糖尿病视网膜病变3期临床试验的队列进行比较。

方法

对693例糖尿病性黄斑水肿患者进行为期36个月的随机对照多中心临床试验,这些患者在美国88个临床地点入组。参与者被分为自我报告的种族/族裔亚组以及三个年龄组之一:18至<60岁、60至<70岁和70岁及以上。

结果

参与者的平均年龄为63岁,72%为白人,视力字母评分中位数为62(约20/63)。未发现任何基线变量在种族亚组之间存在实质性差异。年龄较大的参与者更有可能患2型糖尿病且病程更长。在840只研究眼中,糖尿病视网膜病变最常见的程度为中度(43级)至中度严重(47级)非增殖性疾病。

结论

虽然该队列的种族构成与其他评估糖尿病视网膜病变参与者的大型3期试验队列没有差异,但纳入了许多70岁以上的受试者以及更好的血糖控制水平是其显著特征。

相似文献

1
A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features.一项比较玻璃体内注射曲安奈德与局灶/格栅光凝治疗糖尿病性黄斑水肿的随机试验:基线特征
Retina. 2008 Jul-Aug;28(7):919-30. doi: 10.1097/IAE.0b013e31818144a7.
2
A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.一项比较玻璃体内注射曲安奈德与局部/格栅光凝治疗糖尿病性黄斑水肿的随机试验。
Ophthalmology. 2008 Sep;115(9):1447-9, 1449.e1-10. doi: 10.1016/j.ophtha.2008.06.015. Epub 2008 Jul 26.
3
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.随机试验评估雷珠单抗联合即刻或延迟激光或曲安奈德联合即刻激光治疗糖尿病黄斑水肿。
Ophthalmology. 2010 Jun;117(6):1064-1077.e35. doi: 10.1016/j.ophtha.2010.02.031. Epub 2010 Apr 28.
4
Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.一项比较局灶/格栅光凝与玻璃体内注射曲安奈德治疗糖尿病性黄斑水肿的随机试验的三年随访
Arch Ophthalmol. 2009 Mar;127(3):245-51. doi: 10.1001/archophthalmol.2008.610.
5
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.球周注射曲安奈德联合或不联合局部光凝治疗轻度糖尿病性黄斑水肿的随机试验:一项初步研究
Ophthalmology. 2007 Jun;114(6):1190-6. doi: 10.1016/j.ophtha.2007.02.010.
6
Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.玻璃体内注射曲安奈德联合黄斑激光治疗弥漫性糖尿病性黄斑水肿后的玻璃体后界膜改变
Retina. 2008 Nov-Dec;28(10):1435-42. doi: 10.1097/IAE.0b013e31817f2dae.
7
Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.玻璃体内注射曲安奈德联合序贯格栅样光凝与单纯曲安奈德或单纯光凝治疗糖尿病性黄斑水肿的六个月疗效
Ophthalmology. 2007 Dec;114(12):2162-7. doi: 10.1016/j.ophtha.2007.02.006. Epub 2007 Apr 25.
8
Diabetic macular edema.糖尿病性黄斑水肿
Ophthalmology. 2009 Sep;116(9):1833-4; author reply 1834. doi: 10.1016/j.ophtha.2009.04.010.
9
Diabetic macular edema.糖尿病性黄斑水肿
Ophthalmology. 2009 Jun;116(6):1228.e1; author reply 1228-9. doi: 10.1016/j.ophtha.2009.02.030.
10
Diabetic macular edema.糖尿病性黄斑水肿
Ophthalmology. 2009 Mar;116(3):595; author reply 596-7. doi: 10.1016/j.ophtha.2008.12.016.

引用本文的文献

1
Diabetic retinopathy-recommendations for screening and treatment.糖尿病视网膜病变——筛查与治疗建议
Wien Med Wochenschr. 2025 Jun;175(9-10):253-263. doi: 10.1007/s10354-025-01088-6. Epub 2025 May 9.
2
Visual function and retinal morphological changes after single suprachoroidal delivery of fluocinolone acetonide (Iluvien®) implant in eyes with chronic diabetic macular edema.单次脉络膜上腔注射曲安奈德(Iluvien®)植入物治疗慢性糖尿病性黄斑水肿后眼睛的视觉功能和视网膜形态学变化
Int J Retina Vitreous. 2023 Mar 29;9(1):20. doi: 10.1186/s40942-023-00458-9.
3
Diabetic Macular Oedema Guidelines: An Australian Perspective.糖尿病性黄斑水肿指南:澳大利亚视角
J Ophthalmol. 2023 Feb 14;2023:6329819. doi: 10.1155/2023/6329819. eCollection 2023.
4
Diabetic Retinopathy: An Overview of Treatments.糖尿病视网膜病变:治疗概述
Indian J Endocrinol Metab. 2022 Mar-Apr;26(2):111-118. doi: 10.4103/ijem.ijem_480_21. Epub 2022 Jun 6.
5
Intravitreal steroids for macular edema in diabetes.玻璃体内注射类固醇治疗糖尿病性黄斑水肿
Cochrane Database Syst Rev. 2020 Nov 17;11(11):CD005656. doi: 10.1002/14651858.CD005656.pub3.
6
Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study.现实世界中视力较好的糖尿病性黄斑水肿的观察和治疗结果:OBTAIN 研究。
Acta Diabetol. 2019 Jul;56(7):777-784. doi: 10.1007/s00592-019-01310-z. Epub 2019 Mar 22.
7
Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema.糖尿病黄斑水肿患者玻璃体内注射地塞米松植入物后视力和色觉的变化。
PLoS One. 2018 Jun 26;13(6):e0199693. doi: 10.1371/journal.pone.0199693. eCollection 2018.
8
The Role of Focal Laser in the Anti-Vascular Endothelial Growth Factor Era.聚焦激光在抗血管内皮生长因子时代的作用。
Ophthalmol Eye Dis. 2017 Nov 21;9:1179172117738240. doi: 10.1177/1179172117738240. eCollection 2017.
9
Experience of intravitreal triamcinolone acetonide for treatment of diabetic macular edema among Omani population.玻璃体内注射曲安奈德治疗阿曼人群糖尿病性黄斑水肿的经验。
Oman J Ophthalmol. 2017 Sep-Dec;10(3):177-183. doi: 10.4103/ojo.OJO_173_2016.
10
Diabetic macular oedema: pathophysiology, management challenges and treatment resistance.糖尿病性黄斑水肿:病理生理学、管理挑战与治疗抵抗
Diabetologia. 2016 Aug;59(8):1594-608. doi: 10.1007/s00125-016-3974-8. Epub 2016 May 14.

本文引用的文献

1
Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy.糖尿病患者且糖尿病视网膜病变轻微或无病变者的Stratus光学相干断层扫描视网膜厚度。
Am J Ophthalmol. 2008 May;145(5):894-901. doi: 10.1016/j.ajo.2007.12.025. Epub 2008 Feb 21.
2
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.改良早期糖尿病性视网膜病变研究与轻度黄斑格栅激光光凝术治疗糖尿病性黄斑水肿的策略比较
Arch Ophthalmol. 2007 Apr;125(4):469-80. doi: 10.1001/archopht.125.4.469.
3
Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.鲁比前列酮对糖尿病视网膜病变患者视力丧失的影响。
Ophthalmology. 2006 Dec;113(12):2221-30. doi: 10.1016/j.ophtha.2006.07.032. Epub 2006 Sep 20.
4
An extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) system for grading of diabetic macular edema in the Astemizole Retinopathy Trial.阿咪唑视网膜病变试验中用于糖尿病性黄斑水肿分级的早期治疗糖尿病性视网膜病变研究(ETDRS)系统的扩展。
Curr Eye Res. 2006 Jun;31(6):535-47. doi: 10.1080/02713680600746112.
5
Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).血糖和血压暴露对2型糖尿病并发症风险的累加效应:一项前瞻性观察性研究(英国前瞻性糖尿病研究75)
Diabetologia. 2006 Aug;49(8):1761-9. doi: 10.1007/s00125-006-0297-1. Epub 2006 May 31.
6
Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials.玻璃体内注射曲安奈德治疗糖尿病性视网膜病变和静脉阻塞性疾病相关黄斑水肿:是时候开展临床试验了。
Arch Ophthalmol. 2005 Feb;123(2):258-9. doi: 10.1001/archopht.123.2.258.
7
The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study.激光光凝治疗糖尿病视网膜病变患者的长期效果:早期治疗糖尿病视网膜病变随访研究
Ophthalmology. 2003 Sep;110(9):1683-9. doi: 10.1016/S0161-6420(03)00579-7.
8
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较(英国前瞻性糖尿病研究[UKPDS 33])。英国前瞻性糖尿病研究(UKPDS)小组
Lancet. 1998 Sep 12;352(9131):837-53.
9
The 14-year incidence of visual loss in a diabetic population.糖尿病患者群体中视力丧失的14年发病率。
Ophthalmology. 1998 Jun;105(6):998-1003. doi: 10.1016/S0161-6420(98)96025-0.
10
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.糖尿病强化治疗对胰岛素依赖型糖尿病长期并发症发生及进展的影响。
N Engl J Med. 1993 Sep 30;329(14):977-86. doi: 10.1056/NEJM199309303291401.